ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-0W13231
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Research Report 2023
BUY CHAPTERS

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-0W13231
Report
July 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Eisai Co Ltd
Mundipharma
Qilu Pharma
TEVA
Novartis
Heron Therapeutics
Roche
Mylan NV
Tesaro

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size

In 2024, the global market size of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs was estimated to be worth US$ 2246 million and is forecast to reach approximately US$ 3003 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs key players include Merck, Eisai, Mundipharma, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share about 50%, followed by China, and Europe both have a share about 35 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%. And in terms of application, the largest application is Moderately Emetogenic Chemotherapy, followed by Highly Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotherapy Induced Nausea and Vomiting (CINV) Drugs.
The Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report

Report Metric Details
Report Name Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
CAGR 4.3%
Segment by Type
  • 5-HT3 Inhibitors
  • NK1 Inhibitors
  • Other
Segment by Application
  • Highly Emetogenic Chemotherapy
  • Moderately Emetogenic Chemotherapy
  • Low Emetogenic Chemotherapy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Heron Therapeutics, Roche, Mylan, Tesaro
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market?

Ans: Global top three manufacturers hold a share over 50%.

What is the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market share by type?

Ans: In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%.

Who are the main players in the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report?

Ans: The main players in the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market are Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Heron Therapeutics, Roche, Mylan, Tesaro

What are the Application segmentation covered in the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report?

Ans: The Applications covered in the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report are Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, Other

What are the Type segmentation covered in the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report?

Ans: The Types covered in the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report are 5-HT3 Inhibitors, NK1 Inhibitors, Other

1 Study Coverage
1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Highly Emetogenic Chemotherapy
1.3.3 Moderately Emetogenic Chemotherapy
1.3.4 Low Emetogenic Chemotherapy
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Estimates and Forecasts
2.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2031
2.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2031
2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region: 2024 Versus 2031
2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2020-2031)
2.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region: 2020-2025
2.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Region (2026-2031)
2.3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2020-2031)
2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region: 2020-2025
2.4.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Region (2026-2031)
2.4.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2031)
3.1.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Volume by Type (2020-2031)
3.1.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2020-2031)
3.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2020-2031)
3.1.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2020-2031)
3.1.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type (2020-2031)
3.1.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2031)
3.2.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Volume by Application (2020-2031)
3.2.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2031)
3.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2020-2031)
3.2.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2020-2031)
3.2.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application (2020-2031)
3.2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 5-HT3 Inhibitors of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application
3.3.2 NK1 Inhibitors of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application
3.3.3 Other of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application
4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Manufacturers
4.1 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers by Sales (2020-2025)
4.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturer (2020-2025)
4.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers by Revenue (2020-2025)
4.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturer (2020-2025)
4.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturer (2020-2025)
4.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Covered: Ranking by Revenue
4.4.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Base Distribution, Product Type
4.5.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
4.5.3 Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Type and Application
4.5.4 5-HT3 Inhibitors Market Sales of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Manufacturer
4.5.5 NK1 Inhibitors Market Sales of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Manufacturer
4.5.6 Other Market Sales of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.1.6 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.1.7 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Eisai
5.2.1 Eisai Company Information
5.2.2 Eisai Description, Business Overview
5.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.2.6 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.2.7 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.2.8 Eisai Recent Developments
5.3 Mundipharma
5.3.1 Mundipharma Company Information
5.3.2 Mundipharma Description, Business Overview
5.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.3.6 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.3.7 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.3.8 Mundipharma Recent Developments
5.4 Qilu Pharma
5.4.1 Qilu Pharma Company Information
5.4.2 Qilu Pharma Description, Business Overview
5.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.4.6 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.4.7 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.4.8 Qilu Pharma Recent Developments
5.5 Teva
5.5.1 Teva Company Information
5.5.2 Teva Description, Business Overview
5.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.5.6 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.5.7 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.5.8 Teva Recent Developments
5.6 Novartis
5.6.1 Novartis Company Information
5.6.2 Novartis Description, Business Overview
5.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.6.6 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.6.7 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.6.8 Novartis Recent Developments
5.7 Heron Therapeutics
5.7.1 Heron Therapeutics Company Information
5.7.2 Heron Therapeutics Description, Business Overview
5.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.7.6 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.7.7 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.7.8 Heron Therapeutics Recent Developments
5.8 Roche
5.8.1 Roche Company Information
5.8.2 Roche Description, Business Overview
5.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.8.6 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.8.7 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.8.8 Roche Recent Developments
5.9 Mylan
5.9.1 Mylan Company Information
5.9.2 Mylan Description, Business Overview
5.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.9.6 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.9.7 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.9.8 Mylan Recent Developments
5.10 Tesaro
5.10.1 Tesaro Company Information
5.10.2 Tesaro Description, Business Overview
5.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
5.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Product in 2024
5.10.6 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application in 2024
5.10.7 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Geographic Area in 2024
5.10.8 Tesaro Recent Developments
6 North America
6.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2020-2031
6.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
6.2.1 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2031)
6.2.2 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2031)
6.3 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
6.4 North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Region
7.2.1 Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2020-2031)
7.2.2 Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2020-2031)
7.3 Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
7.4 Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
8 Europe
8.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2020-2031
8.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
8.2.1 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2031)
8.2.2 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2031)
8.3 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
8.4 Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2020-2031
9.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
9.2.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2031)
9.2.2 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2031)
9.3 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
9.4 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country
10.2.1 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2031)
10.2.2 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2031)
10.3 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025)
10.4 Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Supply Chain Analysis
11.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials and Upstream Suppliers
11.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Clients Analysis
11.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Channel and Sales Model Analysis
11.4.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
12 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Dynamics
12.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Trends
12.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Drivers
12.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Challenges
12.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck
Eisai Co Ltd
Mundipharma
Qilu Pharma
TEVA
Novartis
Heron Therapeutics
Roche
Mylan NV
Tesaro
List of Tables
 Table 1. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2020-2025) & (K Units)
 Table 5. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Manufacturer (2020-2025)
 Table 18. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs as of 2024)
 Table 24. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
 Table 26. Manufacturers Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Merck Company Information
 Table 29. Merck Description and Business Overview
 Table 30. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 31. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Merck Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 33. Merck Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 34. Merck Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 35. Merck Recent Developments
 Table 36. Eisai Company Information
 Table 37. Eisai Description and Business Overview
 Table 38. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 39. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Eisai Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 41. Eisai Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 42. Eisai Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 43. Eisai Recent Developments
 Table 44. Mundipharma Company Information
 Table 45. Mundipharma Description and Business Overview
 Table 46. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 47. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Mundipharma Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 49. Mundipharma Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 50. Mundipharma Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 51. Mundipharma Recent Developments
 Table 52. Qilu Pharma Company Information
 Table 53. Qilu Pharma Description and Business Overview
 Table 54. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 55. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Qilu Pharma Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 57. Qilu Pharma Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 58. Qilu Pharma Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 59. Qilu Pharma Recent Developments
 Table 60. Teva Company Information
 Table 61. Teva Description and Business Overview
 Table 62. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 63. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Teva Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 65. Teva Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 66. Teva Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 67. Teva Recent Developments
 Table 68. Novartis Company Information
 Table 69. Novartis Description and Business Overview
 Table 70. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 71. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Novartis Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 73. Novartis Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 74. Novartis Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 75. Novartis Recent Developments
 Table 76. Heron Therapeutics Company Information
 Table 77. Heron Therapeutics Description and Business Overview
 Table 78. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 79. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Heron Therapeutics Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 81. Heron Therapeutics Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 82. Heron Therapeutics Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 83. Heron Therapeutics Recent Developments
 Table 84. Roche Company Information
 Table 85. Roche Description and Business Overview
 Table 86. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 87. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Roche Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 89. Roche Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 90. Roche Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 91. Roche Recent Developments
 Table 92. Mylan Company Information
 Table 93. Mylan Description and Business Overview
 Table 94. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 95. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 96. Mylan Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 97. Mylan Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 98. Mylan Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 99. Mylan Recent Developments
 Table 100. Tesaro Company Information
 Table 101. Tesaro Description and Business Overview
 Table 102. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
 Table 103. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 104. Tesaro Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Product in 2024
 Table 105. Tesaro Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application in 2024
 Table 106. Tesaro Sales Proportion of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Geographic Area in 2024
 Table 107. Tesaro Recent Developments
 Table 108. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
 Table 109. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2026-2031) & (K Units)
 Table 110. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 111. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 112. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025) & (K Units)
 Table 113. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
 Table 114. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2020-2025) & (K Units)
 Table 115. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Region (2026-2031) & (K Units)
 Table 116. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 117. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 118. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025) & (K Units)
 Table 119. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
 Table 120. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
 Table 121. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2026-2031) & (K Units)
 Table 122. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 123. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 124. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025) & (K Units)
 Table 125. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
 Table 126. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
 Table 127. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2026-2031) & (K Units)
 Table 128. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 129. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 130. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025) & (K Units)
 Table 131. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
 Table 132. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2020-2025) & (K Units)
 Table 133. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Country (2026-2031) & (K Units)
 Table 134. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 135. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 136. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2020-2025) & (K Units)
 Table 137. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2020-2025) & (K Units)
 Table 138. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials, Industry Status and Trend
 Table 139. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials and Upstream Suppliers
 Table 140. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Clients Status and Trend
 Table 141. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Typical Clients
 Table 142. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
 Table 143. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Trends
 Table 144. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Drivers
 Table 145. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Challenges
 Table 146. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Picture
 Figure 2. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type in 2024 & 2031
 Figure 4. 5-HT3 Inhibitors Product Picture
 Figure 5. NK1 Inhibitors Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application in 2024 & 2031
 Figure 9. Highly Emetogenic Chemotherapy
 Figure 10. Moderately Emetogenic Chemotherapy
 Figure 11. Low Emetogenic Chemotherapy
 Figure 12. Other
 Figure 13. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Report Years Considered
 Figure 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size 2020-2031 (US$ Million)
 Figure 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2020-2031 (K Units)
 Figure 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Forecast by Region (2020-2031)
 Figure 18. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2020-2031)
 Figure 19. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Forecast by Type (2020-2031)
 Figure 20. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share Forecast by Type (2020-2031)
 Figure 21. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 22. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share Forecast by Application (2020-2031)
 Figure 23. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share Forecast by Application (2020-2031)
 Figure 24. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 25. 5-HT3 Inhibitors of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 26. NK1 Inhibitors of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Other of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Application, 2024 VS 2031
 Figure 28. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Manufacturer in 2024
 Figure 29. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 30. 5-HT3 Inhibitors Market Sales Proportion by Manufacturer in 2024
 Figure 31. NK1 Inhibitors Market Sales Proportion by Manufacturer in 2024
 Figure 32. Other Market Sales Proportion by Manufacturer in 2024
 Figure 33. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2031 (US$ Million)
 Figure 34. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2020-2025)
 Figure 35. North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
 Figure 36. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue 2020-2031 (US$ Million)
 Figure 37. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Region (2020-2031)
 Figure 39. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2020-2025)
 Figure 40. Asia-Pacific Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
 Figure 41. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2020-2031)
 Figure 43. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2020-2031)
 Figure 44. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2020-2025)
 Figure 45. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
 Figure 46. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2020-2025)
 Figure 49. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2020-2025)
 Figure 50. Latin America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
 Figure 51. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 52. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type (2020-2025)
 Figure 55. Middle East and Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Application (2020-2025)
 Figure 56. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Supply Chain (Upstream and Downstream Market)
 Figure 57. Global Production Market Share of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Raw Materials by Region in 2024
 Figure 58. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distribution Channels
 Figure 59. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 60. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Insights Forecast to 2030
Global Chemotherapy induced Nausea and Vomiting Treatment Market Research Report 2025
Global Treatment of Chemotherapy Induced Nausea in Cancer Patients Market Research Report 2025
Chemotherapy induced Nausea and Vomiting Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiemetics for Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemotherapy Induced Neutropenia CIN Drug Market Research Report 2025
Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Insights Forecast to 2030
Cancer Therapeutics and Supportive Care Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemotherapy Induced Oral Mucositis Treatment Market Research Report 2024
Global Chemotherapy Induced Anemia Drug Market Research Report 2024
Postoperative Nausea and Vomiting Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemotherapy Induced Myelosuppression Treatments Market Research Report 2024
Antiemetic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chemotheraphy induced Nausea and Vomitting Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nausea And Vomiting Treatment Market Insights Forecast to 2030
Chemotherapy induced Cardiotoxicity Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ondansetron Hydrochloride Injection Market Research Report 2024
Global Netupitant and Palonosetron Hydrochloride Capsules Market Research Report 2024
Chemotherapy Induced Oral Mucositis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemotherapy Induced Thrombocytopenia Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions